[ad_1]
Everyone is infected with coronavirus. In just four months, the virus has infected 4 million people worldwide and left 260,000 dead. But this time the good news came. Chinese scientists have come a long way to discover a vaccine to prevent the spread of the crown epidemic. They have recently achieved 100 percent success by applying a newly invented vaccine (antidote) to the monkeys’ bodies.
The vaccine, called Picovac, was developed by Beijing-based Synovac Biotech. Follow the conventional antivirus process. When applied to the body of an animal, antibodies are produced that help destroy the virus. Chinese researchers have applied the new vaccine to a group of monkeys of the Rhesus macaque species. Three weeks later, the monkeys were exposed to the coronavirus.
A week later, the monkeys that had been vaccinated in large doses had no crown in their lungs, meaning that the vaccine was able to fight the virus. And monkeys that have not been vaccinated have been infected with coronaviruses and have symptoms of pneumonia. Picovac’s trial on the human body also began in mid-April.
Picovac, meanwhile, is not Corona’s only hope. Following the same process, the Chinese army has developed another vaccine of almost the same type. You have now entered the second phase of human testing.
However, Chinese researchers may face a problem in making the vaccine. Crown infections have dramatically decreased in the country, with only a few hundred patients present. As a result, it will be difficult for them to find volunteers for the experimental application of the vaccine in the human body in a few days. That is why the SARS vaccine was discontinued in 2003.
Source: CGTN
[ad_2]
